Drug, delivery and devices for diabetic retinopathy (3Ds in DR)
Introduction: Diabetic Retinopathy (DR) is one of the most common causes of blindness among the working population worldwide. Clearly, there is an unmet clinical need to find better treatment options for DR. Areas covered: The literature search was conducted on PubMed with no limitation on language...
Main Authors: | Natarajan, Jayaganesh V., Laude, Augustinus, Lim, Tock Han, Venkatraman, Subbu S., Agrawal, Rupesh, Nirmal, Jayabalan, Radhakrishnan, Krishna, Moreno, Miguel |
---|---|
Other Authors: | School of Materials Science & Engineering |
Format: | Journal Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/84621 http://hdl.handle.net/10220/41900 |
Similar Items
-
Serum VEGF levels in infants at risk for developing retinopathy of prematurity
by: S.V. Katsan, et al.
Published: (2019-06-01) -
Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
by: Anil Gangwe, et al.
Published: (2021-01-01) -
Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2019-01-01) -
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
by: Alessandro Arrigo, et al.
Published: (2022-12-01) -
Case report on two diabetic donor eyes with no retinopathy: Clinicopathological and molecular studies
by: Subramaniam Rajesh Bharathi Devi, et al.
Published: (2019-01-01)